Pathogenesis, microbiological and clinical aspects of oral candidiasis (Candidosis) (a review)

Acta Microbiologica et Immunologica Hungarica

Volumn 48, Issue 3-4, 2001, Pages 479-495

  Hermann, P ^a   Berek, Zs ^b   Nagy, G ^a   Kamotsay, K ^b   Rozgonyi, F ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Adhesion of the Candida albicans; Candida albicans; Oral candidiasis

Indexed keywords

ANTIFUNGAL AGENT;

CANDIDA; CANDIDA ALBICANS; CELL ADHESION; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUTH; PATHOGENICITY; REVIEW; THRUSH; VIRULENCE;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CELL ADHESION; HUMANS; IMMUNITY, CELLULAR; MOUTH; VIRULENCE;

EID: 0035756250     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.48.2001.3-4.15     Document Type: Article

References (76)

1. Béládi I., Nász I.: Orvosi mikrobiológia. Semmelweis Kiadó 295 (1993).
2. Bouchara, J., Tronchin, G., Annaix, V., Robert, R., Senet, J.M.: Laminin receptors on Candida albicans germ tubes. Infect Immun 58, 48 (1990).
3. Brassart, D., Woltz, A., Golliard, M., Neeser, J.R.: In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fucα->2Galβ- bearing complex carbohydrates. Infect Immun 59, 1605 (1991).
4. Calderone, R.: Molecular interactions at the interface of Candida albicans and host cells. Arch Med Res 24, 275 (1993).
5. Panagoda, G.J., Samaranayake, L.: A new semi-automated technique for quantification of Candida adherence to denture acrylic surfaces. Mycoses 42, 265 (1999).
6. Samaranayake, Y.H., Wu, C., Samaranayake, L., Ho, L.: The relative pathogenecity of Candida krusei and C. albicans in the rat oral mucosa. J Med Microbiol 47, 1047 (1998).
7. Critchley, I.A., Douglas, L.: Role of glycosides as epithelial cell receptors for Candida albicans. J Gen Microbiol 133, 637 (1987).
8. Holmes, A.R., Gopal, K. Jenkinson, H.F.: Adherence of Candida albicans to a cell-surface polysaccharide receptor on Streptococcus gordonii. Infect Immun 63, 1827 (1995).
9. Hostetter, M.K.: Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev 7, 29 (1994).
10. Lopez-Ribot, J.L., Chaffin, W.L.: Binding of the extracellular matrix component antactin to Candida albicans. Infect Immun 62, 4564 (1994).
11. Negre, E., Vogel, T., Levanon, A., Guy, R., Walsh, T.J., Roberts, D.D.: The collagen-binding domain of fibronectin contains a high affinity binding site for Candida albicans. J Biol Chem 269, 22039 (1994).
12. Ellepola, A.N., Samaranayake, L.: The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells. Arch Oral Biol 43, 879 (1998).
13. Ellepola, A.N., Samaranayake, L.: Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. Arch Oral Biol 43, 999 (1998).
14. Arendorf, T.M., Walker, D.M.: The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 25, 1 (1980).
15. Brown, L.R., Dreizen, S.; Handlers, S.; Johnston, D.A.: The effect of radiation-induced xerostomia on saliva and serum lysozyme and immunoglobulin levels. J Dent Res 54, 740 (1975).
16. Nagy, E.: Changing epidemiology of systemic fungal infections and the possibilities of laboratory diagnostics. Acta Microbiol Immunol Hung 46, 227 (1999).
17. Fox, B.C., Mobley, H.L.T., Wade, J.C.: The Use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts. J Infect Dis 159, 488-494 (1989).
18. MacDonald, F., Odds, F.C.: Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol 129, 431 (1983).
19. Fekete-Forgács, K., Jeney, A., Varga, G., Lenkey. B.: Investigation of α-glycosidase as a potential virulence factor of Candida albicans. J Basic Microbiol 40, 87-92 (2000)
20. Chakrabarti, A., Nayak, N., Talwar, P.: In vitro proteinase production by Candida species. Mycopathologia 114, 163-168 (1991).
21. Arendorf, T.M.; Walker, D.M.; Kingdom, R.J.; Roll, R.J.; Newcombe R.G.: Tobacco smoking and denture wearing in oral candidal leukoplakia. Br Dent J 155, 340 (1983).
22. Macura, A.B., Voss, A., Melchers, W.J.G., Mcis, J.F.G.M., Syslo, Jadviga, Heczko, P.B.: Characterization of pathogenetic determinants of Candida albicans strains. Zbl Bakteriol 287, 501 (1998)
23. Ghannoum, M.A., Abu-Elteen, K.H.: Pathogenecity determinants of Candida. Mycoses 33 (6) 265 (1990).
24. Fitzpatrik, L.R., Wang, J., Le, T.: In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats. Dig Dis Sci 12, 2327 (2000)
25. McGoven, J.J., Parrott, R.H., Emmous, C.W., Ross, S., Burke, F.G., Rice, E.C.: The effect of aureomycin and chloramphenicol on the fungal and bacterial flora of children. N Engl J Med 10, 297 (1953).
26. Kurtzmann, C., Phaff, H.J.: Molecular taxonomy. In: The yeasts. Academic Press, 63 (1987).
27. Samaranayake, L., MacFarlane, T.W.: Factors affecting the in vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin. Arch Oral Biol 27, 869 (1982).
28. Lodder, J.: The Yeasts. A Taxonomic Study. North Holland (1970).
29. MacFarlane, T.W.: Ecology and Epidemiology of Candida. In: Oral candidosis. Wright (1990).
30. Phaff, H.J.: DNA, Enzymes and cell wall. In: The yeasts: A taxonomic study. Elsevier Science Publishers B.V. (1984).
31. Samaranayake, L., MacFarlane, T.W.: Oral candidosis. Butterworth (1990).
32. Nikawa, H., Samaranayake, L., Tenuovo, J.: The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch Oral Biol 38, 1057 (1993).
33. Matsumoto, M., Matsubana, S., Matsuni, T., Tamura, M., Hattori, R., Nomura, H., Ono, M., Yokoto, T.: Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun 55, 2775 (1987).
34. Hill, I.R. et al.: Studies of bactericidal activity to Escherichia coli of porcine serum and colostral immunoglobulin and the role of lysozyme with secretory IgA. Immunology 26, 1239 (1974).
35. Tobgi, R.S., Samaranayake, L., MacFarlane, T.W.: In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 3, 35 (1988).
36. Rayhan, R., Xu, L., Santarpia, R., Tylende, C. A., Pollock, J.J.: Antifungal activities of salivary histidine-rich polypeptides agarost Candida albicans and other oral yeasts flora. Oral Microbiol Immunol 7, 51 (1992).
37. Olsen, I.: Chemotaxonomy of yeasts. Acta Odontol Scand 48, 19 (1990).
38. Tabak, L., Mandel, I.D., Karland, D., Baurmash, H.: Alterations in lactoferrin in salivary gland disease. J Dent Res 57, 43 (1978).
39. Odds, F.C.: Candida and candidosis: A review and bibliography. Balhere Tindall (1988).
40. Marson, L., Heremans, J.F.: Lactoferrin in milk from different species. Com Biochem Physiol 39, 119 (1971).
41. Tenovuo, J., Valtakoski, J., Knuuttila, M.L.: Antibacterial activity of lactoperoxidase adsorbed by human salivary sediment and hydroxyapatite. Caries Res 11 257 (1977).
42. Klebanoff, S.J.: Role of the superoxide anion in the myeloperoxidase-mediatcd antimicrobial system. J Biol Chem 249 3724 (1974).
43. Okuda, T., Yasuoka, T., Okra, N.: Myeloperoxidase deficiency as a predisposing factor for deep mucocutaneous candidiasis. J Oral Maxillofac Surg 49 183 (1991).
44. Pereira, H.A., Hosking, C.S.: The role of complement and antibody in opsonization and intracellular killing of Candida albicans. Clin Ex Immunol 57, 307 (1984).
45. Prinz Gy.: Invasive mycoses in patients with neutropenia and after bone marrow transplantation (in Hungarian). Epidemiológia és klinikum. Infektiológia és Klinikai Mikrobiológia. 6. évf. 1. sz. (1998).
46. Djeu, J.Y., Blanchard, D.R., Halkias D., Friedman, H.: Growth Inhibition of Candida albicans by human polymorphonuclear neutrophils: Activation by imerferon-gamma and tumor necrosis factor. J Immunol 137, 2980 (1986).
47. Santoni, G., Gismondi, A., Liu, J.H., Punturieri, A., Santoni, A., Frati, L. et al.: Candida albicans expresses a fibronectin receptor amigenically related to α5β1 integrin. Microbiol 140, 2971 (1971).
48. Lombardi, G., Di Massimo, A.M., Del Gallo, P., Vismora, D., Piccolella, E., Pugliese, 0., Colizzi, V.: Mechanisms of action of an antigen non-specific inhibitor factor produced by human T-cells stimulated by MPPs and PPD. Cell Immunol 98, 434 (1986).
49. Papadimitriou, J.M., Ashman, R.B.: Macrophages: Current views on their differentiation, structure and function. J Ultrastruct Pathol 13, 343 (1989).
50. Barlow, A.J.E., Chattaway, F.W.: Observations on the carriers of Candida albicans in man. Br J Dermatol 81, 103 (1969).
51. Samaranaye, L.P., Wu, T.: The expression of secreted aspartyl proteinases of Candida species in human whole saliva. J Med Microbiol 48, 711 (1999).
52. Budtz-Jorgensen, E.: The significance of Candida albicans in denture stomatitis. Scand J Dent Res 82, 151 (1974).
53. Davenport, J.C.: The oral distribution of Candida in denture stomatitis. Br Dent J 129, 151 (1970).
54. Bánóczy, J.: A leukoplakia. Fogorv Szle 73, 1 (1980).
55. Budtz-Jorgensen, E.: Candida-associated denture stomatitis and angular cheilitis. In: Oral Candidosis. Buyyerworth (1990).
56. Oliver, D.E., Shillitoe, W.J.: Effects of smoking on the prevalence and intraoral distribution of Candida albicans. J Oral Pathol 13, 265 (1984).
57. Mason, A.P.P., Weber, J.C.P., Willoughby, J.M.T.: Oral carriage of Candida albicans, ABO blood groups and secretor status in healthy subjects. J Med Vet Mycol 26, 49 (1988).
58. Mitchell, K.G., Bradley, J.A., Ledingham, I.M.C.A., Hamilton, D.N.H.: Candida colonization of the oral cavity. Surg Gynecol Obstet 154, 870 (1982).
59. Pindborg, J.J., Nielsen, H.: Significance of oral lesions: Oral candidiasis. J Dent Res 68, 859 (1989).
60. Scully, C.: Chronic atrophic candidosis. Leading Article 437 (1986).
61. Bánóczy, J.: Follow-up studies in oral leukoplakia. J Maxillofac Surg 5, 69 (1977).
62. Bánóczy, J.: Novel classification of precanceroses of the oral cavity (in Hungarian). Fogorv Szle 78, 22 (1985).
63. Bánóczy, J., Csiba, Á.: Comparative studies of the clinical manifestation and histological characteristics in oral leukoplakia (in Hungarian). Fogorv Szle 63, 65 (1970).
64. Sugar, L., Bánóczy, J.: Relationship between leukoplakia and carcinoma (in Hungarian).. Fogorv Szle 63, 225 (1970).
65. Cawson, R.A.: Chronic oral candidosis. Denture stomatitis and chronic hyperplastic candidosis. E&S Livingstone, pp. 139 (1966).
66. Cawson, R.A., Binnie, W.H.: Candida leukoplakia and carcinoma. A possible relationship. University of Iowa Press, 59, (1980).
67. Daniels, T.E., Schwartz 0., Larsen, V., Dabelsteen, E., Pindborg, J.J.: Langerhans cells in candidal leukoplakia. J Oral Pathol 14, 733 (1985).
68. Pindborg, J.J.: Oral leukoplakia. Austral Dent J 16, 83 (1971).
69. Newton, A.V.: Denture sore mouth. A possible etiology. Br Dent J 112, 357 (1962).
70. Razek, M.K., Shaaban, N.: Histochemical and histopathological studies of alveolar mucosa under complete dentures. J Prosthet Dent 39, 29 (1978).
71. Holmstrup, P., Bessermann, M.: Clinical, therapeutic and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol 56, 388 (1983).
72. Ellepola, A.N., Samaranayake, L.P.: The in vitro post-antifungal effect of nystatin on Candida species of oral origin. J Oral Pathol Med 28, 112 (1999).
73. Epstein, J.: Antifungal therapy in oropharyngeal mycotic infections. Oral Surg Oral Med Oral Pathol 69, 32 (1990).
74. Hay, R.Y.: Overview of studies of fluconazole in oropharyngeal candidiasis. Revs Infect Dis 12, 334 (1990).
75. Lewis, M., Samaranayake, L.P., Lamey, P.: Diagnosis and treatment of oral candidosis. J Oral Maxillofac Surg 49, 996 (1991).
76. Siegman-Igra, Y., Raban, M.Y.: Failure of fluconazole in systemic candidiasis. Eur J Clin Microbiol Infect Dis 11, 201 (1992).